Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole in Pediatric Participants With Healed Erosive Esophagitis
NCT04821310Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of pantoprazole in erosive esophagitis (EE), sponsored by Pfizer. Started Jan 2022; status: terminated.
02
Drugs
pantoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT04821310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821310.